View in EDS

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.

Saved in:
Bibliographic Details
Title: Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
Authors: Hurvitz SA; University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 USA., Bosserman LD; Wilshire Oncology Medical Group, Inc., La Verne, CA USA., Chan D; Torrance Memorial Hospital, Redondo Beach, CA USA., Hagenstad CT; Suburban Hematology and Oncology, Lawrenceville, GA USA., Kass FC; Cancer Center of Santa Barbara, Santa Barbara, CA USA., Smith FP; Georgetown University School of Medicine, Washington, DC USA., Rodriguez GI; South Texas Oncology and Hematology, P.A., San Antonio, TX USA., Childs BH; sanofi U.S., Bridgewater, NJ USA., Slamon DJ; University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 USA.
Source: SpringerPlus [Springerplus] 2014 May 12; Vol. 3, pp. 244. Date of Electronic Publication: 2014 May 12 (Print Publication: 2014).
Publication Type: Journal Article
Journal Info: Publisher: SpringerPlus Country of Publication: Switzerland NLM ID: 101597967 Publication Model: eCollection Cited Medium: Print ISSN: 2193-1801 (Print) Linking ISSN: 21931801 NLM ISO Abbreviation: Springerplus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24860718
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hurvitz+SA%22">Hurvitz SA</searchLink>; University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 USA.<br /><searchLink fieldCode="AU" term="%22Bosserman+LD%22">Bosserman LD</searchLink>; Wilshire Oncology Medical Group, Inc., La Verne, CA USA.<br /><searchLink fieldCode="AU" term="%22Chan+D%22">Chan D</searchLink>; Torrance Memorial Hospital, Redondo Beach, CA USA.<br /><searchLink fieldCode="AU" term="%22Hagenstad+CT%22">Hagenstad CT</searchLink>; Suburban Hematology and Oncology, Lawrenceville, GA USA.<br /><searchLink fieldCode="AU" term="%22Kass+FC%22">Kass FC</searchLink>; Cancer Center of Santa Barbara, Santa Barbara, CA USA.<br /><searchLink fieldCode="AU" term="%22Smith+FP%22">Smith FP</searchLink>; Georgetown University School of Medicine, Washington, DC USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+GI%22">Rodriguez GI</searchLink>; South Texas Oncology and Hematology, P.A., San Antonio, TX USA.<br /><searchLink fieldCode="AU" term="%22Childs+BH%22">Childs BH</searchLink>; sanofi U.S., Bridgewater, NJ USA.<br /><searchLink fieldCode="AU" term="%22Slamon+DJ%22">Slamon DJ</searchLink>; University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101597967%22">SpringerPlus</searchLink> [Springerplus] 2014 May 12; Vol. 3, pp. 244. <i>Date of Electronic Publication: </i>2014 May 12 (<i>Print Publication: </i>2014).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SpringerPlus%22">SpringerPlus </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597967 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2193-1801 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221931801%22">21931801 </searchLink><i>NLM ISO Abbreviation: </i>Springerplus <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24860718
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/2193-1801-3-244
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 244
    Titles:
      – TitleFull: Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hurvitz SA
      – PersonEntity:
          Name:
            NameFull: Bosserman LD
      – PersonEntity:
          Name:
            NameFull: Chan D
      – PersonEntity:
          Name:
            NameFull: Hagenstad CT
      – PersonEntity:
          Name:
            NameFull: Kass FC
      – PersonEntity:
          Name:
            NameFull: Smith FP
      – PersonEntity:
          Name:
            NameFull: Rodriguez GI
      – PersonEntity:
          Name:
            NameFull: Childs BH
      – PersonEntity:
          Name:
            NameFull: Slamon DJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 05
              Text: 2014 May 12
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 2193-1801
          Numbering:
            – Type: volume
              Value: 3
          Titles:
            – TitleFull: SpringerPlus
              Type: main
ResultId 1